Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: BioMarin Pharmaceutical Inc., 3 years.
BioMarin Pharmaceutical Inc.
Director
Geron Corporation
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 15, 2024 | Geron Corporation | Option exercise | +35,000 | $1.94 | $67,900 |
| May 15, 2024 | Geron Corporation | Open-market sale | −35,000 | $3.75 | $131,250 |
| May 23, 2023 | BioMarin Pharmaceutical Inc. | Grant or award | +4,190 | — | — |
| May 11, 2023 | Geron Corporation | Option exercise | +35,000 | $1.10 | $38,500 |
| May 11, 2023 | Geron Corporation | Open-market sale | −35,000 | $3.00 | $105,000 |
| Apr 3, 2023 | BioMarin Pharmaceutical Inc. | Option exercise | +8,500 | $67.81 | $576,385 |
| Apr 3, 2023 | BioMarin Pharmaceutical Inc. | Open-market sale | −8,500 | $97.09 | $825,265 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.